InspireMD (NSPR) Liabilities and Shareholders Equity (2010 - 2025)
InspireMD posted quarterly Liabilities and Shareholders Equity of $69.4 million for Q4 2025, up 48.28% year-on-year from $46.8 million in Q4 2024, and down 11.56% on a QoQ basis from $78.5 million in Q3 2025.
InspireMD (NSPR) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $69.4 million in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 48.28% year-over-year to $69.4 million; the trailing twelve-month figure through Dec 2025 stood at $219.9 million (up 12.78% YoY), and the FY2025 full-year result was $69.4 million, up 48.28% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $69.4 million, down from $78.5 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $78.5 million in Q3 2025 and bottomed at $19.9 million in Q1 2023.
- The 5-year median for Liabilities and Shareholders Equity is $44.5 million (2021), against an average of $44.2 million.
- The widest annual swing landed in 2021, when Liabilities and Shareholders Equity jumped 558.56%; it then plunged 43.36% in 2023.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $39.7 million in 2021, then sank by 37.92% to $24.7 million in 2022, then surged by 93.25% to $47.6 million in 2023, then decreased by 1.75% to $46.8 million in 2024, then jumped by 48.28% to $69.4 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $69.4 million (Q4 2025), $78.5 million (Q3 2025), and $33.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 69.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.40 Mn |
| Sep 30, 2025 | 78.47 Mn |
| Jun 30, 2025 | 33.34 Mn |
| Mar 31, 2025 | 38.67 Mn |
| Dec 31, 2024 | 46.81 Mn |
| Sep 30, 2024 | 50.48 Mn |
| Jun 30, 2024 | 55.66 Mn |
| Mar 31, 2024 | 42.03 Mn |
| Dec 31, 2023 | 47.64 Mn |
| Sep 30, 2023 | 50.02 Mn |
| Jun 30, 2023 | 53.64 Mn |
| Mar 31, 2023 | 19.92 Mn |
| Dec 31, 2022 | 24.65 Mn |
| Sep 30, 2022 | 28.06 Mn |
| Jun 30, 2022 | 32.77 Mn |
| Mar 31, 2022 | 35.17 Mn |
| Dec 31, 2021 | 39.71 Mn |
| Sep 30, 2021 | 42.61 Mn |
| Jun 30, 2021 | 46.38 Mn |
| Mar 31, 2021 | 48.64 Mn |
| Dec 31, 2020 | 17.78 Mn |
| Sep 30, 2020 | 15.61 Mn |
| Jun 30, 2020 | 17.74 Mn |
| Mar 31, 2020 | 7.39 Mn |
| Dec 31, 2019 | 9.88 Mn |
| Sep 30, 2019 | 11.62 Mn |
| Jun 30, 2019 | 9.28 Mn |
| Mar 31, 2019 | 10.06 Mn |
| Dec 31, 2018 | 12.29 Mn |
| Sep 30, 2018 | 13.93 Mn |
| Jun 30, 2018 | 9.47 Mn |
| Mar 31, 2018 | 7.29 Mn |
| Dec 31, 2017 | 6.11 Mn |
| Sep 30, 2017 | 7.11 Mn |
| Jun 30, 2017 | 8.91 Mn |
| Mar 31, 2017 | 10.51 Mn |
| Dec 31, 2016 | 9.41 Mn |
| Sep 30, 2016 | 12.46 Mn |
| Jun 30, 2016 | 3.02 Mn |
| Dec 31, 2015 | 5.69 Mn |
| Jun 30, 2015 | 13.56 Mn |
| Dec 31, 2014 | 11.46 Mn |
| Jun 30, 2014 | 13.96 Mn |
| Mar 31, 2014 | 19.51 Mn |
| Dec 31, 2013 | 23.97 Mn |
| Sep 30, 2013 | 17.69 Mn |
| Jun 30, 2013 | 20.75 Mn |
| Mar 31, 2013 | 9.80 Mn |
| Dec 31, 2012 | 11.60 Mn |
| Sep 30, 2012 | 13.62 Mn |
| Jun 30, 2012 | 16.01 Mn |
| Mar 31, 2012 | 8.53 Mn |
| Dec 31, 2011 | 10.47 Mn |
| Sep 30, 2011 | 12.07 Mn |
| Jun 30, 2011 | 11.34 Mn |
| Dec 31, 2010 | 4.36 Mn |